Please ensure Javascript is enabled for purposes of website accessibility

Basepaws Launches Most Extensive Dog DNA Test, Disease Risk Detection

By Pet Age Staff//October 6, 2023//

Basepaws Launches Most Extensive Dog DNA Test, Disease Risk Detection

By: Pet Age Staff//October 6, 2023//

Listen to this article

Press release: Basepaws

Basepaws, a leader in feline DNA testing and genetics, is entering the canine market with the most extensive DNA test for dogs, accelerating the health genetic testing landscape. Basepaws Breed + Health Dog DNA Test helps pet owners shift from reactive to proactive care, offering easy swabbing and mobile-friendly results for a simplified experience.

Our pets can be masters at hiding pain until a disease becomes advanced.  Basepaws dog DNA test can identify health risks earlier — even before painful symptoms appear.  Earlier detection of risks can also offer additional opportunities for treatment and improvement in a pet’s quality of life, in collaboration with your veterinarian.

A quick and easy-to-use oral swab test offers pet parents invaluable insights into their dog’s genetic blueprint. These insights include over 280 genetic markers linked to hereditary conditions in dogs – more genetic markers than any other pet DNA test. Additionally, Basepaws provides a comprehensive breakdown of breed similarity by comparing the dog’s genome to a vast database of 200+ canine breeds, and details on more than 30 distinct genetic trait markers that influence their unique physical characteristics, such as coat length, texture, color, pattern, as well as body size, shape, and structure.

Basepaws leads the pack as the first company in pet genetics to employ Illumina Next Generation Sequencing (NGS) technology. This involves conducting in-house whole genome sequencing (WGS) and delivering data on approximately 2.5 billion nucleotide bases for each canine genome analyzed. NGS has found application in diverse fields of biological research, ranging from the study of COVID-19 patients, to unraveling the mutational landscapes of cancer. Now, this cutting-edge technology is at your disposal, providing comprehensive genetic insights into your pet’s health and breed through Basepaws.

With Basepaws, a dog’s DNA sample undergoes sequencing on the latest and most advanced NGS machine on the market, the NovaSeq X Plus by Illumina. This allows pet owners to access invaluable insights into their pet’s health, enabling them to make well-informed decisions about their beloved companion’s overall well-being and care.

“Basepaws is dedicated to helping pets lead longer, healthier lives by equipping pet parents with the knowledge and resources to provide proactive care. With a passion-fueled team, including pet parents, geneticists, veterinarians, and the world’s leading animal health provider, we aim to be the go-to choice for dog DNA testing worldwide,” said Anna Skaya, CEO and founder of Basepaws.

“Basepaws’ entry into the dog genetics market showcases their creativity and innovation.  Building on their track record of setting industry standards with the cat DNA test, their history suggests a promising future in the dog DNA domain.  Zoetis enthusiastically supports this strategic expansion, anticipating significant advancements in the field and improved health outcomes for our canine companions,” commented Wafaa Mamilli, executive vice president, chief digital & technology officer, and group president for China, Brazil, and Precision Animal Health at Zoetis, which acquired Basepaws in 2022.